Healthcare

Wockhardt Hospitals, in collaboration with the South Asian Liver Institute, has launched an Early Recovery Program (ERP) for liver transplantation in Mumbai. This program aims to reduce the financial burden of liver transplants by approximately 20-30 per cent and improve patient outcomes through advanced techniques.

The Indian government is taking a significant step towards improving vaccine safety and monitoring by allowing mothers to report any side effects their infants experience after routine immunizations on the U-WIN platform. This new system will not only streamline the reporting process but also provide valuable data to the government, enabling them to better understand and address potential adverse events.

The court expressed disappointment with the affidavits submitted by district officers from Haridwar, including Ayurveda and Unani officers, allowing the Uttarakhand State Licensing Authority to file additional affidavits. The Centre defended its decision to issue a letter directing State/UT licensing authorities regarding misleading advertisements related to Ayurvedic and Ayush products, as per the Drugs and Cosmetic Rules, 1945.

Medical tourism in India is projected to exceed pre-pandemic levels in 2024, driven by the country's top-notch healthcare infrastructure, skilled medical professionals, and cost-effective treatment options. This growth is attracting major hospital chains to expand their international outreach and invest in new medical technologies, positioning India as a leading destination for medical value travel.

AstraZeneca has announced the global withdrawal of its COVID-19 vaccine, Vaxzevria, citing a decline in demand due to surplus availability of other vaccines. The company stated that the decision to withdraw is not related to safety concerns but is a result of decreased demand and a shift towards newer vaccine variants.